Covaxin gets nod for use in kids above 12

In October 2021, the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO), which evaluates vaccine applications, had recommended granting an approval for Covaxin for children aged between 2 and 18 years. However, the regulator has decided to restrict the approval to only teens, instead of the younger age group.

via Economictimes

No comments